Back to Search
Start Over
S3. Rituximab for ANCA-associated vasculitides: the French experience.
- Source :
-
Presse medicale (Paris, France : 1983) [Presse Med] 2013 Apr; Vol. 42 (4 Pt 2), pp. 534-6. Date of Electronic Publication: 2013 Feb 26. - Publication Year :
- 2013
- Subjects :
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis immunology
Antibodies, Antineutrophil Cytoplasmic blood
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal, Murine-Derived adverse effects
Cyclophosphamide adverse effects
Cyclophosphamide therapeutic use
Dose-Response Relationship, Drug
Drug Administration Schedule
France
Granulomatosis with Polyangiitis drug therapy
Granulomatosis with Polyangiitis immunology
Humans
Immunologic Factors adverse effects
Immunosuppressive Agents therapeutic use
Infliximab
Prospective Studies
Randomized Controlled Trials as Topic
Retrospective Studies
Rituximab
Treatment Outcome
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis drug therapy
Antibodies, Monoclonal, Murine-Derived therapeutic use
Immunologic Factors therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2213-0276
- Volume :
- 42
- Issue :
- 4 Pt 2
- Database :
- MEDLINE
- Journal :
- Presse medicale (Paris, France : 1983)
- Publication Type :
- Academic Journal
- Accession number :
- 23453207
- Full Text :
- https://doi.org/10.1016/j.lpm.2013.01.050